Skip to main content
SpringerLink
Log in
Book cover

Lung Cancer pp 503–514Cite as

The Future of Lung Cancer

  • Chapter
  • First Online:

  • 2258 Accesses

Part of the book series: Current Clinical Oncology ((CCO))

Abstract

Current treatments for lung cancer have limited effectiveness and unfortunately, therefore, prognosis remains poor. Major insights into the molecular pathogenesis of lung cancers have led to new and exciting approaches to improve prevention, detection, staging and treatment of lung cancer. This chapter reviews recent advances and discusses the potential clinical applications of these novel strategies, in the future.

Grant Support: NCI Lung Cancer SPORE P50CA70907, DOD PROSPECT W81XWH-07-1-0306, an IASLC Fellowship (Spinola).

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   279.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Doll R, Hill AB (1954) The mortality of doctors in relation to their smoking habits; a preliminary report. Br Med J 1:1451-1455

    Article  PubMed  CAS  Google Scholar 

  2. Graham EA, Singer JJ (1984) Landmark article Oct 28, 1933. Successful removal of an entire lung for carcinoma of the bronchus. JAMA 251:257-260

    Article  PubMed  CAS  Google Scholar 

  3. Johnson DH (2000) Evolution of cisplatin-based chemotherapy in non-small cell lung cancer: a historical perspective and the eastern cooperative oncology group experience. Chest 117:133S-137S

    Article  PubMed  CAS  Google Scholar 

  4. Schiller JH, Harrington D, Belani CP et al (2002) Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer. N Engl J Med 346:92-98

    Article  PubMed  CAS  Google Scholar 

  5. Weinstein IB, Joe AK (2006) Mechanisms of disease: oncogene addiction - a rationale for molecular targeting in cancer therapy. Nat Clin Pract 3:448-457

    Article  CAS  Google Scholar 

  6. Inamura K, Fujiwara T, Hoshida Y et al (2005) Two subclasses of lung squamous cell carcinoma with different gene expression profiles and prognosis identified by hierarchical clustering and non-negative matrix factorization. Oncogene 24:7105-7113

    Article  PubMed  CAS  Google Scholar 

  7. Beer DG, Kardia SL, Huang CC et al (2002) Gene-expression profiles predict survival of patients with lung adenocarcinoma. Nat Med 8:816-824

    PubMed  CAS  Google Scholar 

  8. Ramaswamy S, Ross KN, Lander ES, Golub TR (2003) A molecular signature of metastasis in primary solid tumors. Nat Genet 33:49-54

    Article  PubMed  CAS  Google Scholar 

  9. Moriya Y, Iyoda A, Kasai Y et al (2009) Prediction of lymph node metastasis by gene expression profiling in patients with primary resected lung cancer. Lung Cancer 64(1):86-91

    Article  PubMed  Google Scholar 

  10. Potti A, Mukherjee S, Petersen R et al (2006) A genomic strategy to refine prognosis in early-stage non-small-cell lung cancer. N Engl J Med 355:570-580

    Article  PubMed  CAS  Google Scholar 

  11. Chen HY, Yu SL, Chen CH et al (2007) A five-gene signature and clinical outcome in non-small-cell lung cancer. N Engl J Med 356:11-20

    Article  PubMed  CAS  Google Scholar 

  12. Shedden K, Taylor JM, Enkemann SA et al (2008) Gene expression-based survival prediction in lung adenocarcinoma: a multi-site, blinded validation study. Nat Med 14:822-827

    Article  PubMed  CAS  Google Scholar 

  13. Lu Y, Lemon W, Liu PY et al (2006) A gene expression signature predicts survival of patients with stage I non-small cell lung cancer. PLoS Med 3:e467

    Article  PubMed  Google Scholar 

  14. Michiels S, Koscielny S, Hill C (2007) Interpretation of microarray data in cancer. Br J Cancer 96:1155-1158

    Article  PubMed  CAS  Google Scholar 

  15. Kikuchi T, Daigo Y, Katagiri T et al (2003) Expression profiles of non-small cell lung cancers on cDNA microarrays: identification of genes for prediction of lymph-node metastasis and sensitivity to anti-cancer drugs. Oncogene 22:2192-2205

    Article  PubMed  CAS  Google Scholar 

  16. Bild AH, Yao G, Chang JT et al (2006) Oncogenic pathway signatures in human cancers as a guide to targeted therapies. Nature 439:353-357

    Article  PubMed  CAS  Google Scholar 

  17. Hsu DS, Balakumaran BS, Acharya CR et al (2007) Pharmacogenomic strategies provide a rational approach to the treatment of cisplatin-resistant patients with advanced cancer. J Clin Oncol 25:4350-4357

    Article  PubMed  CAS  Google Scholar 

  18. Nagrath S, Sequist LV, Maheswaran S et al (2007) Isolation of rare circulating tumour cells in cancer patients by microchip technology. Nature 450:1235-1239

    Article  PubMed  CAS  Google Scholar 

  19. Maheswaran S, Sequist LV, Nagrath S et al (2008) Detection of mutations in EGFR in circulating lung-cancer cells. N Engl J Med 359:366-377

    Article  PubMed  CAS  Google Scholar 

  20. Yanagisawa K, Shyr Y, Xu BJ et al (2003) Proteomic patterns of tumour subsets in non-small-cell lung cancer. Lancet 362:433-439

    Article  PubMed  CAS  Google Scholar 

  21. Solomon B, Gregorc V, Taguchi F et al (2006) Prediction of clinical outcome in non-small cell lung cancer (NSCLC) patients treated with gefitinib using matrix-assisted laser desorption/ionization-time of flight mass spectrometry (MALDI-TOF MS) of serum. In: ASCO annual meeting proceedings part I. June 20, 2006. J Clin Oncol 24(Suppl 18S):7004

    Google Scholar 

  22. Wistuba II, Behrens C, Virmani AK et al (2000) High resolution chromosome 3p allelotyping of human lung cancer and preneoplastic/preinvasive bronchial epithelium reveals multiple, discontinuous sites of 3p allele loss and three regions of frequent breakpoints. Cancer Res 60:1949-1960

    PubMed  CAS  Google Scholar 

  23. Palmisano WA, Divine KK, Saccomanno G et al (2000) Predicting lung cancer by detecting aberrant promoter methylation in sputum. Cancer Res 60:5954-5958

    PubMed  CAS  Google Scholar 

  24. Belinsky SA, Liechty KC, Gentry FD et al (2006) Promoter hypermethylation of multiple genes in sputum precedes lung cancer incidence in a high-risk cohort. Cancer Res 66:3338-3344

    Article  PubMed  CAS  Google Scholar 

  25. Li R, Todd NW, Qiu Q et al (2007) Genetic deletions in sputum as diagnostic markers for early detection of stage I non-small cell lung cancer. Clin Cancer Res 13:482-487

    Article  PubMed  CAS  Google Scholar 

  26. Wester HJ (2007) Nuclear imaging probes: from bench to bedside. Clin Cancer Res 13:3470-3481

    Article  PubMed  CAS  Google Scholar 

  27. Pal A, Glekas A, Doubrovin M et al (2006) Molecular imaging of EGFR kinase activity in tumors with 124I-labeled small molecular tracer and positron emission tomography. Mol Imaging Biol 8:262-277

    Article  PubMed  CAS  Google Scholar 

  28. Beer AJ, Lorenzen S, Metz S et al (2008) Comparison of integrin alphaVbeta3 expression and glucose metabolism in primary and metastatic lesions in cancer patients: a PET study using 18F-galacto-RGD and 18F-FDG. J Nucl Med 49:22-29

    Article  PubMed  Google Scholar 

  29. Stearman RS, Dwyer-Nield L, Grady MC, Malkinson AM, Geraci MW (2008) A macrophage gene expression signature defines a field effect in the lung tumor microenvironment. Cancer Res 68:34-43

    Article  PubMed  CAS  Google Scholar 

  30. Zhong L, Roybal J, Chaerkady R et al (2008) Identification of secreted proteins that mediate cell-cell interactions in an in vitro model of the lung cancer microenvironment. Cancer Res 68:7237-7245

    Article  PubMed  CAS  Google Scholar 

  31. Ramirez RD, Sheridan S, Girard L et al (2004) Immortalization of human bronchial epithelial cells in the absence of viral oncoproteins. Cancer Res 64:9027-9034

    Article  PubMed  CAS  Google Scholar 

  32. Sato M, Vaughan MB, Girard L et al (2006) Multiple oncogenic changes (K-RAS(V12), p53 knockdown, mutant EGFRs, p16 bypass, telomerase) are not sufficient to confer a full malignant phenotype on human bronchial epithelial cells. Cancer Res 66:2116-2128

    Article  PubMed  CAS  Google Scholar 

  33. Whitehurst AW, Bodemann BO, Cardenas J et al (2007) Synthetic lethal screen identification of chemosensitizer loci in cancer cells. Nature 446:815-819

    Article  PubMed  CAS  Google Scholar 

  34. Dutt A, Wong KK (2006) Mouse models of lung cancer. Clin Cancer Res 12:4396s-4402s

    Article  PubMed  CAS  Google Scholar 

  35. Jackson EL, Willis N, Mercer K et al (2001) Analysis of lung tumor initiation and progression using conditional expression of oncogenic K-ras. Genes Dev 15:3243-3248

    Article  PubMed  CAS  Google Scholar 

  36. Guerra C, Mijimolle N, Dhawahir A et al (2003) Tumor induction by an endogenous K-ras oncogene is highly dependent on cellular context. Cancer Cell 4:111-120

    Article  PubMed  CAS  Google Scholar 

  37. Meuwissen R, Linn SC, Linnoila RI, Zevenhoven J, Mooi WJ, Berns A (2003) Induction of small cell lung cancer by somatic inactivation of both Trp53 and Rb1 in a conditional mouse model. Cancer Cell 4:181-189

    Article  PubMed  CAS  Google Scholar 

  38. Jordan CT, Guzman ML, Noble M (2006) Cancer stem cells. N Engl J Med 355:1253-1261

    Article  PubMed  CAS  Google Scholar 

  39. Glinsky GV, Berezovska O, Glinskii AB (2005) Microarray analysis identifies a death-from-cancer signature predicting therapy failure in patients with multiple types of cancer. J Clin Invest 115:1503-1521

    Article  PubMed  CAS  Google Scholar 

  40. Liu R, Wang X, Chen GY et al (2007) The prognostic role of a gene signature from tumorigenic breast-cancer cells. N Engl J Med 356:217-226

    Article  PubMed  CAS  Google Scholar 

  41. Bonnet D, Dick JE (1997) Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat Med 3:730-737

    Article  PubMed  CAS  Google Scholar 

  42. Lapidot T, Sirard C, Vormoor J et al (1994) A cell initiating human acute myeloid leukaemia after transplantation into SCID mice. Nature 367:645-648

    Article  PubMed  CAS  Google Scholar 

  43. Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ, Clarke MF (2003) Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci USA 100:3983-3988

    Article  PubMed  CAS  Google Scholar 

  44. Singh SK, Hawkins C, Clarke ID et al (2004) Identification of human brain tumour initiating cells. Nature 432:396-401

    Article  PubMed  CAS  Google Scholar 

  45. Patrawala L, Calhoun T, Schneider-Broussard R et al (2006) Highly purified CD44+ prostate cancer cells from xenograft human tumors are enriched in tumorigenic and metastatic progenitor cells. Oncogene 25:1696-1708

    Article  PubMed  CAS  Google Scholar 

  46. Ricci-Vitiani L, Lombardi DG, Pilozzi E et al (2007) Identification and expansion of human colon-cancer-initiating cells. Nature 445:111-115

    Article  PubMed  CAS  Google Scholar 

  47. Ho MM, Ng AV, Lam S, Hung JY (2007) Side population in human lung cancer cell lines and tumors is enriched with stem-like cancer cells. Cancer Res 67:4827-4833

    Article  PubMed  CAS  Google Scholar 

  48. Kim CF, Jackson EL, Woolfenden AE et al (2005) Identification of bronchioalveolar stem cells in normal lung and lung cancer. Cell 121:823-835

    Article  PubMed  CAS  Google Scholar 

  49. Liu S, Dontu G, Wicha MS (2005) Mammary stem cells, self-renewal pathways, and carcinogenesis. Breast Cancer Res 7:86-95

    Article  PubMed  CAS  Google Scholar 

  50. Dontu G, Jackson KW, McNicholas E, Kawamura MJ, Abdallah WM, Wicha MS (2004) Role of Notch signaling in cell-fate determination of human mammary stem/progenitor cells. Breast Cancer Res 6:R605-R615

    Article  PubMed  CAS  Google Scholar 

  51. Taipale J, Beachy PA (2001) The Hedgehog and Wnt signalling pathways in cancer. Nature 411:349-354

    Article  PubMed  CAS  Google Scholar 

  52. Liu S, Dontu G, Mantle ID et al (2006) Hedgehog signaling and Bmi-1 regulate self-renewal of normal and malignant human mammary stem cells. Cancer Res 66:6063-6071

    Article  PubMed  CAS  Google Scholar 

  53. Reya T, Clevers H (2005) Wnt signalling in stem cells and cancer. Nature 434:843-850

    Article  PubMed  CAS  Google Scholar 

  54. Olsen CL, Hsu PP, Glienke J, Rubanyi GM, Brooks AR (2004) Hedgehog-interacting protein is highly expressed in endothelial cells but down-regulated during angiogenesis and in several human tumors. BMC Cancer 4:43

    Article  PubMed  Google Scholar 

  55. Nickoloff BJ, Osborne BA, Miele L (2003) Notch signaling as a therapeutic target in cancer: a new approach to the development of cell fate modifying agents. Oncogene 22:6598-6608

    Article  PubMed  CAS  Google Scholar 

  56. Daniel VC, Peacock CD, Watkins DN (2006) Developmental signalling pathways in lung cancer. Respirology 11:234-240

    Article  PubMed  Google Scholar 

  57. Yang ZJ, Wechsler-Reya RJ (2007) Hit ‘em where they live: targeting the cancer stem cell niche. Cancer Cell 11:3-5

    Article  PubMed  CAS  Google Scholar 

  58. Piccirillo SG, Reynolds BA, Zanetti N et al (2006) Bone morphogenetic proteins inhibit the tumorigenic potential of human brain tumour-initiating cells. Nature 444:761-765

    Article  PubMed  CAS  Google Scholar 

  59. Bao S, Wu Q, McLendon RE et al (2006) Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature 444:756-760

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Hamon Center for Therapeutic Oncology Research, University of Texas Southwestern Medical Center, 6000 Harry Hines Blvd, Dallas, TX, 75390-8593, USA

    John D. Minna

Authors
  1. Sophie Sun
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Joan H. Schiller
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Monica Spinola
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. John D. Minna
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to John D. Minna .

Editor information

Editors and Affiliations

  1. M. D. Anderson Cancer Center, University of Texas, Holcombe Blvd. 1515, Houston, 77030, U.S.A.

    David J. Stewart

Rights and permissions

Reprints and permissions

Copyright information

© 2010 Humana Press, a part of Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Sun, S., Schiller, J.H., Spinola, M., Minna, J.D. (2010). The Future of Lung Cancer. In: Stewart, D. (eds) Lung Cancer. Current Clinical Oncology. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-60761-524-8_20

Download citation

  • DOI: https://doi.org/10.1007/978-1-60761-524-8_20

  • Published:

  • Publisher Name: Humana Press, Totowa, NJ

  • Print ISBN: 978-1-60761-523-1

  • Online ISBN: 978-1-60761-524-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation